Aimei Health Technology Co., Ltd (Ticker: AFJKR) is a pioneering entity in the healthcare sector, specializing in the integration of artificial intelligence to enhance patient care through advanced diagnostic and therapeutic solutions. Positioned to leverage the expanding demand for digital health services, the company focuses on operational efficiencies that support robust growth in a rapidly evolving market. Aimei’s commitment to innovation and its development of next-generation healthcare products not only improve patient outcomes but also present compelling opportunities for institutional investors looking to participate in the transformative landscape of health technology.
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | 0.00% |
| Return on Assets | -1.08% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $-1.32 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | -43.40% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | 0 |
| Float | $1.44M |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Volatility is currently expanding
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on AFJKR and any ticker you trade — then tracks every position and per-strategy win rate.